tradingkey.logo
tradingkey.logo
Search

Gelteq Ltd

GELS
Add to Watchlist
0.520USD
-0.031-5.61%
Close 07-31 16:00ETQuotes delayed by 15 min
5.82MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-5.61%

5 Days

-25.78%

1 Month

-22.37%

6 Months

-46.39%

Year to Date

-34.99%

1 Year

-69.94%

Key Figures
0.553Open
0.638High
19.96KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.18%Turnover Ratio
0.551Prev. Close
0.520Low
6.94KTurnover
LossP/E Static
0.59P/B
0.00%Div Yield TTM
-31.47%ROA
3.51052wk High
0.24Volume Ratio
-6.65MNet Profit
11.18MShares
-1.0701EPS TTM
--Beta
-42.99%ROE
0.38752wk Low
21.42%Amplitude
-707.96%Gross Margin
5.82MMarket Cap
-0.34Reward/Risk
14.36%Risk Rate

Gelteq Ltd News

More news coming soon, stay tuned...

Indicators

Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.012
Sell
RSI(14)
41.529
Neutral
STOCH(KDJ)(9,3,3)
10.110
Sell
ATR(14)
0.088
High Vlolatility
CCI(14)
-61.402
Neutral
Williams %R
79.947
Sell
TRIX(12,20)
-0.409
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.579
Sell
MA10
0.622
Sell
MA20
0.591
Sell
MA50
0.641
Sell
MA100
0.647
Sell
MA200
0.809
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Gelteq Ltd Info

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
Ticker SymbolGELS
CompanyGelteq Ltd
CEOGivoni (Nathan Jacob)
Websitehttps://www.gelteq.com

Shareholders

Shareholders
Shareholders
Proportion
Markoff (Jeffrey)
22.79%
Golik (David)
9.45%
Givoni (Nathan Jacob)
6.13%
Crestmont Pty Ltd
6.00%
Szewach (Simon Hayden)
3.16%
Other
52.47%

FAQs

What is the current price of Gelteq Ltd (GELS)?

The current price of Gelteq Ltd (GELS) is 0.52.

What is the symbol of Gelteq Ltd?

The ticker symbol of Gelteq Ltd is GELS.

What is the 52-week high of Gelteq Ltd?

The 52-week high of Gelteq Ltd is 3.51.

What is the 52-week low of Gelteq Ltd?

The 52-week low of Gelteq Ltd is 0.39.

What is the market capitalization of Gelteq Ltd?

The market capitalization of Gelteq Ltd is 5.82M.

What is the Earnings Per Share (EPS TTM) of Gelteq Ltd (GELS)?

The Earnings Per Share (EPS TTM) of Gelteq Ltd (GELS) is -0.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.